What does Foghorn Therapeutics Inc. do?
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate,…
What is Foghorn Therapeutics Inc.'s P/E and P/B ratio?
Foghorn Therapeutics Inc. has a P/E ratio of -2.1 and a P/B ratio of -1.47.
What is Foghorn Therapeutics Inc.'s debt-to-equity ratio?
Foghorn Therapeutics Inc. has a debt-to-equity ratio of -0.38.
How much does Foghorn Therapeutics Inc. owe compared with what it owns?
Foghorn Therapeutics Inc. owes $1.40 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Foghorn Therapeutics Inc.'s Positivity rank?
Foghorn Therapeutics Inc. is ranked #6,374 of 6,774 companies globally and #3,645 of 4,000 in United States on PositoAI, with a Positivity Score of -17,874.
Does Foghorn Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Foghorn Therapeutics Inc..
Where can I read the latest news about Foghorn Therapeutics Inc.?
Recent headlines about Foghorn Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Foghorn Therapeutics Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Foghorn Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.